Riskpilot← Back to searchSign inGet full accessDr Mimosa Oy
OYActiveY-tunnus 3102308-8Kauppiaskatu 13Medical specialists activities · NACE 8622Est. 20192 employeeswww.drmimosa.fi
Revenue 2025
EUR 223K
+42% vs 2024
EBITDA margin
20.2%
+130% vs 2024
Equity ratio
89.9%
Financial strength
Net profit 2025
EUR 34K
+138% vs 2024
| Revenue | EUR 223K | +42% |
| EBITDA | EUR 45K | +130% |
| Net profit | EUR 34K | +138% |
| Total assets | EUR 98K | +63% |
| Equity | EUR 88K | +63% |
| Employees | 2 | — |
Legal name
Dr Mimosa Oy
Y-tunnus number
3102308-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
30. marraskuuta 2019
Share capital
EUR 0
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Terveyspalvelut, lääkäripalvelut, terveydenhuollon tuotekehitys, konsultointi sekä muu laillinen liiketoiminta
Address
Kauppiaskatu 13
Email
mimosa@drmimosa.fi
Website
www.drmimosa.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 128 | 25 | 81 | 157 | 223 |
| Staff expenses | −63 | −14 | −33 | −43 | −57 |
| EBITDA | 7 | 3 | 22 | 20 | 45 |
| Depreciation & amort. | −1 | −1 | −1 | −2 | −2 |
| EBIT | 6 | 2 | 22 | 18 | 43 |
| Net financials | −0 | — | −0 | −0 | −0 |
| Profit before tax | 6 | 2 | 22 | 18 | 43 |
| Tax | 3 | 1 | 4 | 4 | 9 |
| Net profit | 3 | 2 | 17 | 14 | 34 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 23 | 29 | 46 | 60 | 98 |
| Equity | 21 | 22 | 40 | 54 | 88 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 2 | 7 | 6 | 6 | 10 |
| Total debt | 2 | 7 | 6 | 6 | 10 |
EBITDA margin
20.2%
This company
15.8%
Market median
+28% vs market
20212025
Equity ratio
89.9%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
38.7%
This company
18.4%
Market median
+110% vs market
20212025
Net profit margin
15.3%
This company
8.1%
Market median
+89% vs market
20212025
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2019 |
| Former (2) | ||
JI Deputy Member | Deputy Member | 2019 – 2020 |
TT Deputy Member | Deputy Member | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Mimosa Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mimosa Katri Anna Uoti | Chief Executive Officer | 0 companies |
| Jasmin Ilona Maria Levo | Deputy Member | 0 companies |
| Timo Tapio Huusela | Deputy Member | 0 companies |
| Janne Heikki Tapani Uoti | Board of Directors | 0 companies |